Patients with obesity and type 2 diabetes can expect different changes in glucose homeostasis following weight loss from surgical vs. medical interventions, likely due to effects on insulin, glucagon-like peptide 1 and gastrointestinal inhibitory peptide secretion, according to a presenter here.
